Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

OHR Pharmaceutical Inc (NASDAQ:OHRP)

1.55
Delayed Data
As of Jan 17
 0.00 / 0.00%
Today’s Change
1.40
Today|||52-Week Range
4.50
+3.33%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization91.1K466.3K1.2M1.2M
 
 
 
 
 
 
Operating ExpensesGross Income-91.1K-466.3K-1.2M-1.2M
 
 
 
 
 
General Expenses4.5M8.7M16.3M24.1M
 
 
 
 
 
Research And Development2.5M3.5M8.8M16.5M
 
 
 
 
 
Total Operating Expenses4.6M9.1M17.5M25.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-4.6M-9.1M-17.5M-25.3M
 
 
 
 
 
Extraordinary Credit0.000.002.6M710.3K
 
 
 
Extraordinary Charge-1.1M0.00-338.9K-1.2M
 
 
 
 
Pre-Tax Equity Earnings---10.6K-103.1K0.00
 
 
 
Interest Expense On Debt4.7K5.6K6.0K0.00
 
 
 
 
Other Expenses90.8K8.5K78.8K3.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-5.7M-9.1M-15.2M-25.8M
 
 
 
 
 
Net Income-5.7M-9.1M-15.2M-25.8M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.7M22.1M28.4M31.3M
 
 
 
 
 
Shares To Calculate EPS Diluted18.7M22.1M28.4M31.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.30-$0.41-$0.54-$0.82
 
 
 
 
 
EPS Diluted-$0.30-$0.41-$0.54-$0.82